Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Sep 7, 2016
Insider Transaction Report
Form 4
Gunn George W
Director
Transactions
- Award
Ordinary Shares
2016-09-05+20,000→ 37,000 total - Exercise/Conversion
Restricted Share Units
2016-09-05+3,600→ 3,600 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying)
Footnotes (1)
- [F1]3,600 of the Restricted Share Units shall vest and become convertible on 7/1/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting.